Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

PLoS pathogens | 2009

Elite suppressors (ES) are a rare subset of HIV-1-infected individuals who are able to maintain HIV-1 viral loads below the limit of detection by ultra-sensitive clinical assays in the absence of antiretroviral therapy. Mechanism(s) responsible for this elite control are poorly understood but likely involve both host and viral factors. This study assesses ES plasma-derived envelope glycoprotein (env) fitness as a function of entry efficiency as a possible contributor to viral suppression. Fitness of virus entry was first evaluated using a novel inducible cell line with controlled surface expression levels of CD4 (receptor) and CCR5 (co-receptor). In the context of physiologic CCR5 and CD4 surface densities, ES envs exhibited significantly decreased entry efficiency relative to chronically infected viremic progressors. ES envs also demonstrated slow entry kinetics indicating the presence of virus with reduced entry fitness. Overall, ES env clones were less efficient at mediating entry than chronic progressor envs. Interestingly, acute infection envs exhibited an intermediate phenotypic pattern not distinctly different from ES or chronic progressor envs. These results imply that lower env fitness may be established early and may directly contribute to viral suppression in ES individuals.

Pubmed ID: 19360131 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R21 AI049170
  • Agency: NIAID NIH HHS, United States
    Id: AI49170
  • Agency: NIAID NIH HHS, United States
    Id: R56 AI049170
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI067854
  • Agency: NIAID NIH HHS, United States
    Id: AI 28697
  • Agency: NIAID NIH HHS, United States
    Id: AI57005
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI07024
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI 060567
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007024
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI057005
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI052021
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI047033
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI041534
  • Agency: NIAID NIH HHS, United States
    Id: AI067854
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024143
  • Agency: NIAID NIH HHS, United States
    Id: P30 AI028697
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI058894
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI067854
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI52021
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM07250
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI049170
  • Agency: NIAID NIH HHS, United States
    Id: AI058894
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI060567
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007250
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI025879

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions